학술논문
ALK inhibitors downregulate the expression of death receptor 4 in ALK-mutant lung cancer cells via facilitating Fra-1 and c-Jun degradation and subsequent AP-1 suppression
Document Type
Article
Author
Source
In Neoplasia August 2023 42
Subject
Language
ISSN
1476-5586